THORACIC CT-SCAN WITH EGFR MUTATIONS IN PULMONARY ADENOCARCINOMA PATIENTS WITH PULMONARY METASTASES AT DR. MOEWARDI HOSPITAL, SURAKARTA, INDONESIA
Downloads
Highlights
- The thoracic CT scan can be an alternative evaluation before administering EGFR-targeting medicine to patients.
- EGFR is now a therapeutic target for lung cancer.
Abstract
Background: EGFR mutation is one of the molecular markers associated with prognosis and therapy in lung adenocarcinoma patients, including with lung metastases. The predominant imaging modality for assessing lung cancer is a chest CT scan, which correlates with prognosis. Objective: This study aimed to explore the association between characteristics of lung adenocarcinoma based on chest CT-Scan and EGFR mutation in lung adenocarcinoma with lung metastases. Material and Method: This study involved 65 lung adenocarcinoma patients in Dr. Moewardi Hospital, Surakarta, Indonesia, from January 2018-December 2020. Result: Chest CT-Scan and EGFR mutation were assessed in all subjects. EGFR mutation was found in 32 (49.8%) subjects. The risk of EGFR mutation was found to be higher in patients with lung adenocarcinoma who had lung metastases in a peripheral location (OR=11.56; 95%CI 3.57-37.33; p<0.001), tumor size <4 cm (OR=8.00; 95%CI 2.64-24.22; p<0.001), and semi-solid density (OR=5.21; 95%CI 1.79-15.19; p=0.002). Conclusion: EGFR mutation is associated with tumor location, size, and thickness based on chest CT-Scan in lung adenocarcinoma with lung metastases patients.
Barta, J. A., Powell, C. A., Wisnivesky, J. P. 2019. Global epidemiology of lung cancer. Annals of Global Health, 85(1). doi: 10.5334/aogh.2419.
Grigoriu, B., Berghmans, T., Meert, A.-P. 2015. Management of EGFR mutated nonsmall cell lung carcinoma patients. European Respiratory Journal, 45(4): 1132–1141. doi: 10.1183/09031936.00156614.
de Groot, P. M., Wu, C.C., Carter, B.W., Munden, R.F. 2018. The epidemiology of lung cancer. Translational Lung Cancer Research, 7(3): 220–233. doi: 10.21037/tlcr.2018.05.06.
Guan, J., Chen, M., Xiao, N., Li, L., Yang, M., et al. 2016. EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET/CT scan. Medical Oncology, 33(1): 1. doi: 10.1007/s12032-015-0714-8.
Harrison PT, Vyse S, Huang PH. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Semin Cancer Biol. 2020 Apr;61:167-179. doi: 10.1016/j.semcancer.2019.09.015. Epub 2019 Sep 25. PMID: 31562956; PMCID: PMC7083237.
Hasegawa, M., Sakai, F., Ishikawa, R., Kimura, F., Ishida, H., et al. 2016. CT features of epidermal growth factor receptor–mutated adenocarcinoma of the lung: Comparison with nonmutated adenocarcinoma. Journal of Thoracic Oncology, 11(6): 819–826. doi: 10.1016/j.jtho.2016.02.010.
Imai, H., Kaira, K., Minato, K. 2017. Clinical significance of post-progression survival in lung cancer. Thoracic Cancer, 8(5): 379–386. doi: 10.1111/1759-7714.12463.
Komite Penanggulangan Kanker Nasional. 2017. Kanker paru. Jakarta: Kementerian Kesehatan RI.
Kumari, N., Singh, S., Haloi, D., Mishra, S.K., Krishnani, N., et al. 2019. Epidermal growth factor receptor mutation frequency in squamous cell carcinoma and its diagnostic performance in cytological samples: A molecular and immunohistochemical study. World Journal of Oncology, 10(3): 142–150. doi: 10.14740/wjon1204.
Kusumawardhani, I.AJ.D., Karang, L.K.A., Candrawati, N.W., Saputra, H., Sriwidyani, N.P., et al. 2022. Risk factors and chellenging management of lung adenocarcinoma in young adult women: Case series. Jurnal Respirasi, 8(2):94-98. doi: 10.20473/jr.v8-I.2.2022.94-98.
Lemjabbar-Alaoui H, Hassan OU, Yang YW, Buchanan P. Lung cancer: Biology and treatment options. Biochim Biophys Acta. 2015 Dec;1856(2):189-210. doi: 10.1016/j.bbcan.2015.08.002. Epub 2015 Aug 19. PMID: 26297204; PMCID: PMC4663145.
Liu, Y., Kim, J., Qu, F., Liu, s., Wang, H., et al. 2016. CT features associated with epidermal growth factor receptor mutation status in patients with lung adenocarcinoma. Radiology, 280(1): 271–280. doi: 10.1148/radiol.2016151455.
Qiu, X., Yuan, H., Sima, B. 2019. Relationship between EGFR mutation and computed tomography characteristics of the lung in patients with lung adenocarcinoma. Thoracic Cancer, 10(2): 170–174. doi: 10.1111/1759-7714.12928.
Rizzo, S., Petrella, F., Buscarino, V., De Maria, F., Raimondi, S., et al. 2016. CT radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer. European Radiology, 26(1): 32–42. doi: 10.1007/s00330-015-3814-0.
Syahruddin, E., Wulandari, L., Sri Muktiati, N., Rima, A., Soeroso, N., et al. 2018. Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients. Lung Cancer: Targets and Therapy, 9: 25–34. doi: 10.2147/LCTT.S154116.
Torre, L. A., Siegel, R. L., Jemal, A. 2016. Lung cancer statistics. in Springer. USA: Advances in Experimental Medicine and Biology: 1–19. doi: 10.1007/978-3-319-24223-1_1.
Tseng, C.-H., Chen, K., Hsu, K.H., Tseng, J.S., Ho, C.C., et al. 2016. EGFR mutation and lobar location of lung adenocarcinoma. Carcinogenesis, 37(2): 157–162. doi: 10.1093/carcin/bgv168.
Vivi, S. 2020. Hubungan asupan energi dan zat gizi makro dengan status gizi pasien ca paru yang mendapat kemoterapi di ruang Rawat Inap di RSUD Dr. Moewardi di Surakarta. Universitas Muhammadiyah Surakarta.
Wu, S.-G., Chang Y., Yu, C.J., Yang, P.C., Shih, J.Y. 2017. Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors. ERJ Open Research, 3(3), pp. 00092–02016. doi: 10.1183/23120541.00092-2016.
Wulandari, L, Soegiarto, G, Febriani, A, Fatmawati, F., Sahrun 2021. Comparison of detection of Epidermal Growth Factor Receptor (EGFR) gene mutation in peripheral blood plasma (Liquid Biopsy) with cytological specimens in lung adenocarcinoma patients. Indian Journal of Surgical Oncology. 12: 65-71. doi.org: 10.1007/s13193-020-01046-1.
Yue, J.-Y., Chen, J., Zhou, F.M., Hu, Y., Li, M.S., et al. 2018. CT-pathologic correlation in lung adenocarcinoma and squamous cell carcinoma. Medicine, 97(50): e13362. doi: 10.1097/MD.0000000000013362.
Zhang, M. X., Tan, W., Zhang, R.X., Tian, Y.L., Gao, H.M., et al. 2014. Case report long-term survival of non-small-cell lung cancer patients with EGFR inhibitor treatment. Genetics and Molecular Research, 13(4): 8657–8660. doi: 10.4238/2014.October.27.5.
Copyright (c) 2023 Viska Wahyu Arianti, Widiastuti Soewondo, Sulistiyani Kusumaningrum, Muhammad Lukman Hermansyah, Yusup Subagio Sutanto, Hari Wujoso
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. The journal allows the author(s) to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution 4.0 International License (CC-BY).
